Vanda Pharmaceuticals Inc (VNDA)

May 23, 2026

Vanda a new buy at B. Riley on 'historic discount' - MSN

May 23, 2026

May 20, 2026

Vanda Pharmaceuticals Q3 Earnings Preview - MSN

May 20, 2026

May 20, 2026

Vanda (VNDA) director donates 25,836 shares of common stock - Stock Titan

May 20, 2026

May 19, 2026

VNDA: 2026 revenue guidance raised on new launches, with BYSANTI and NEREUS set to drive future growth - TradingView

May 19, 2026

May 17, 2026

How The Vanda Pharmaceuticals (VNDA) Investment Story Is Shifting With BYSANTI And Nereus - Yahoo Finance

May 17, 2026

May 16, 2026

Vanda Pharmaceuticals stock (US92178N1054): Regulatory setback, sharp drop and rising short interest - AD HOC NEWS

May 16, 2026

May 13, 2026

Vanda: A Long-Term Pharma Growth Idea, Despite Q1 Earnings Miss (NASDAQ:VNDA) - Seeking Alpha

May 13, 2026

May 13, 2026

Vanda targets $240M-$290M 2026 revenue as it introduces $10M-$30M NEREUS sales outlook - MSN

May 13, 2026

May 13, 2026

HC Wainwright Brokers Lower Earnings Estimates for VNDA - MarketBeat

May 13, 2026

May 12, 2026

State Street (VNDA) discloses 3.02M shares, 5.1% ownership on 13G - Stock Titan

May 12, 2026

May 12, 2026

Earnings call transcript: Vanda Pharmaceuticals Q1 2026 misses EPS forecast, stock drops By Investing.com - Investing.com South Africa

May 12, 2026

May 12, 2026

Earnings call transcript: Vanda Pharmaceuticals Q1 2026 misses EPS forecast, stock drops - Investing.com Nigeria

May 12, 2026

May 11, 2026

H.C. Wainwright cuts Vanda Pharmaceuticals stock price target on higher costs - Investing.com UK

May 11, 2026

May 11, 2026

H.C. Wainwright Maintains Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Cuts Target Price to $21 - Moomoo

May 11, 2026

May 11, 2026

VNDA Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus

May 11, 2026

May 11, 2026

HC Wainwright Cuts Vanda Pharmaceuticals (NASDAQ:VNDA) Price Target to $21.00 - MarketBeat

May 11, 2026

May 11, 2026

H.C. Wainwright cuts Vanda Pharmaceuticals stock price target on higher costs By Investing.com - Investing.com South Africa

May 11, 2026

May 09, 2026

Vanda Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript - GuruFocus

May 09, 2026

May 08, 2026

VNDA SEC FilingsVanda Pharma 10-K, 10-Q, 8-K Forms - Stock Titan

May 08, 2026

May 08, 2026

Vanda Pharmaceuticals Announces Participation at May 2026 Investor Conferences - BioSpace

May 08, 2026

May 08, 2026

Vanda Pharmaceuticals (VNDA) Losses Deepen To US$239.5 Million LTM Reinforcing Bearish Narratives - Sahm

May 08, 2026

May 07, 2026

VNDA Reports Strong Q1 Growth with New Product Launches - GuruFocus

May 07, 2026

May 07, 2026

VNDA Projected Revenue Forecast for 2026 at $258.2 Million - GuruFocus

May 07, 2026

May 07, 2026

Vanda Pharmaceuticals 1Q Loss/Shr 82c >VNDA - Moomoo

May 07, 2026

May 07, 2026

Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences - Intellectia AI

May 07, 2026

May 07, 2026

Truist Financial Maintains Vanda Pharmaceuticals(VNDA.US) With Buy Rating, Announces Target Price $18 - Moomoo

May 07, 2026

May 07, 2026

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2026 Earnings Call Transcript - Insider Monkey

May 07, 2026

May 07, 2026

[10-Q] Vanda Pharmaceuticals Inc. Quarterly Earnings Report - Stock Titan

May 07, 2026

May 07, 2026

Vanda Pharmaceuticals Q1 Earnings Call Highlights - Yahoo Finance

May 07, 2026

May 07, 2026

Vanda: Q1 Earnings Snapshot - theheraldreview.com

May 07, 2026

May 07, 2026

Vanda maps out 3 May investor events, including a live webcast - Stock Titan

May 07, 2026

May 06, 2026

MSN Money - MSN

May 06, 2026

May 06, 2026

Earnings call transcript: Vanda Pharmaceuticals misses Q1 2026 forecasts, stock rises By Investing.com - Investing.com South Africa

May 06, 2026

May 06, 2026

Vanda Pharmaceuticals Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 06, 2026

May 06, 2026

Earnings call transcript: Vanda Pharmaceuticals misses Q1 2026 forecasts, stock rises - Investing.com Nigeria

May 06, 2026

May 06, 2026

Vanda (VNDA) Q1 2026 Earnings Call Transcript - The Globe and Mail

May 06, 2026

May 06, 2026

Document - SEC.gov

May 06, 2026

May 06, 2026

VANDA PHARMACEUTICALS INC (NASDAQ:VNDA) Misses Q1 2026 Estimates as Top-Line Growth Slows - ChartMill

May 06, 2026

May 06, 2026

Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

May 06, 2026

May 06, 2026

Vanda Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

May 06, 2026

May 06, 2026

VANDA PHARMACEUTICALS ($VNDA) Releases Q1 2026 Earnings - Quiver Quantitative

May 06, 2026

May 06, 2026

Q1 2026 Vanda Pharmaceuticals Inc Earnings Call Transcript - GuruFocus

May 06, 2026

May 06, 2026

Vanda Pharmaceuticals (NASDAQ: VNDA) boosts 2026 revenue view on new approvals - Stock Titan

May 06, 2026

May 06, 2026

Vanda Pharmaceuticals Reports First Quarter 2026 Financial Results - marketscreener.com

May 06, 2026

May 06, 2026

Vanda Pharmaceuticals Reports First Quarter 2026 Financial Results – Company Announcement - Financial Times

May 06, 2026

May 06, 2026

[EFFECT] Vanda Pharmaceuticals Inc. SEC Filing - Stock Titan

May 06, 2026

May 06, 2026

How many employees work at Vanda Pharmaceuticals? - Revelio Labs

May 06, 2026

May 06, 2026

Vanda Pharmaceuticals Inc. Raises Revenue Guidance for the Full-Year 2026 - marketscreener.com

May 06, 2026

May 05, 2026

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026 - Quantisnow

May 05, 2026